20 May 2013
Keywords: iolab, livostin, approved, usa, johnson, unit, levocabastine
Article | 22 November 1993
Johnson & Johnson unit Iolab's Livostin (levocabastine) ophthalmic
suspension has been approved in the USA for the temporary relief of the
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
15 November 1993
29 November 1993
17 May 2013
© 2013 thepharmaletter.com